Patents by Inventor Jennifer Leeds

Jennifer Leeds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINOTHIAZOLES AND THEIR USES
    Publication number: 20170015704
    Abstract: The present application describes organic compounds of Formula (I) and pharmaceutical compositions thereof, and their use for the treatment, prevention and/or amelioration of diseases, particularly bacterial infections.
    Type: Application
    Filed: September 22, 2016
    Publication date: January 19, 2017
    Applicant: Novartis AG
    Inventors: Simon Bushell, Matthew J. Lamarche, Jennifer Leeds, Lewis Whitehead
  • Aminothiazoles and their uses
    Patent number: 9492496
    Abstract: The present application describes organic compounds of Formula (I) and pharmaceutical compositions thereof, and their use for the treatment, prevention and/or amelioration of diseases, particularly bacterial infections.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: November 15, 2016
    Assignee: Novartis AG
    Inventors: Simon Bushell, Matthew J. Lamarche, Jennifer Leeds, Lewis Whitehead
  • AMINOTHIAZOLES AND THEIR USES
    Publication number: 20140274878
    Abstract: The present application describes organic compounds of Formula (I) and pharmaceutical compositions thereof, and their use for the treatment, prevention and/or amelioration of diseases, particularly bacterial infections.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 18, 2014
    Applicant: NOVARTIS AG
    Inventors: Simon Bushell, Matthew J. Lamarche, Jennifer Leeds, Lewis Whitehead
  • AMINIOTHIAZOLES AND THEIR USES
    Publication number: 20130231275
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases particularly bacterial infections.
    Type: Application
    Filed: April 17, 2013
    Publication date: September 5, 2013
    Applicant: Novartis AG
    Inventors: Simon Bushell, Matthew J. Lamarche, Jennifer Leeds, Lewis Whitehead
  • Aminothiazoles and their uses
    Patent number: 8426356
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases particularly bacterial infections.
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: April 23, 2013
    Assignee: Novartis AG
    Inventors: Simon Bushell, Matthew J. LaMarche, Jennifer Leeds, Lewis Whitehead
  • Antibacterial compounds and processes for its production
    Patent number: 8183341
    Abstract: This invention relates to a novel antibiotic compounds, pharmaceutically acceptable salts and derivatives thereof, and to methods for obtaining such compounds.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: May 22, 2012
    Assignee: Novartis AG
    Inventors: Matthew J. Lamarche, Jennifer A. Leeds, Phillipp Krastel, Hans-Ulrich Naegeli
  • ANTIBACTERIAL COMPOUNDS AND PROCESSES FOR ITS PRODUCTION
    Publication number: 20100093615
    Abstract: This invention relates to a novel antibiotic compounds, pharmaceutically acceptable salts and derivatives thereof, and to methods for obtaining such compounds.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 15, 2010
    Inventors: Matthew J. Lamarche, Jennifer A. Leeds, Phillipp Krastel, Hans-Ulrich Naegeli
  • Aminothiazoles and their Uses
    Publication number: 20090156628
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases particularly bacterial infections.
    Type: Application
    Filed: December 12, 2008
    Publication date: June 18, 2009
    Inventors: Simon Bushell, Matthew J. LaMarche, Jennifer Leeds, Lewis Whitehead
  • N-Formyl Hydrozyamine Compounds
    Publication number: 20090062537
    Abstract: Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.
    Type: Application
    Filed: March 2, 2007
    Publication date: March 5, 2009
    Inventors: Kwangho Lee, Jennifer A. Leeds